雅虎香港電視

Drug Enforcement Administration (DEA) officials has set the date for a hearing to possibly reclassify marijuana to a Schedule 1 drug on December 2, after the 2024 presidential election. Cannabis stocks, including Curaleaf (CURLF), Tilray (TLRY), Green Thumb (GTBIF), Cresco Labs (CRLBF), and Verano Holdings (VRNOF), are sliding on this news.

For more expert insight and the latest market action, click here to watch this full episode of Market Domination.

This post was written by Luke Carberry Mogan.